Invention Grant
- Patent Title: Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis
- Patent Title (中): 靶向T淋巴细胞治疗肌萎缩性侧索硬化
-
Application No.: US13689375Application Date: 2012-11-29
-
Publication No.: US08946301B2Publication Date: 2015-02-03
- Inventor: Steven Perrin , John Lincecum , Alan Gill , Fernando Vieira
- Applicant: ALS Therapy Development Institute
- Applicant Address: US MA Cambridge
- Assignee: ALS Therapy Development Institute
- Current Assignee: ALS Therapy Development Institute
- Current Assignee Address: US MA Cambridge
- Agency: Pepper Hamilton LLP
- Agent Thomas Engellenner; Reza Mollaaghababa
- Main IPC: A01N33/02
- IPC: A01N33/02 ; A61K31/135 ; C07C215/20 ; A61K31/145 ; A61K31/137
Abstract:
Methods and therapeutic compositions are disclosed for treating neurodegenerative disorders and, in particular Amyotrophic Lateral Sclerosis, using sphingosine1-phosphate receptor modulators, such as fingolimod or a pharmaceutically acceptable salt, hydrate, or solvate thereof.
Public/Granted literature
- US20130150454A1 TARGETING OF T-LYMPHOCYTES TO TREAT AMYOTROPHIC LATERAL SCLEROSIS Public/Granted day:2013-06-13
Information query
